Nektar Therapeutics | Kostnadene For Salg

Cost Of Sales Endring Dato
Cipla INR 23.13B 762.6M 2023-09
Eisai JPY 36.43B 7.49B 2023-09
Gilead Sciences USD 1.61B 46M 2023-12
Grifols EUR 965.65M 79.34M 2023-09
Ironwood Pharmaceuticals USD 0 0 2021-12
Roche Holding CHF 7.62B 1.33B 2023-06



Nektar Therapeutics Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2024.